Published in J Cardiovasc Magn Reson on January 18, 2012
Evaluation of elevated mean pulmonary arterial pressure based on magnetic resonance 4D velocity mapping: comparison of visualization techniques. PLoS One (2013) 0.97
Magnetic resonance and computed tomography imaging of the structural and functional changes of pulmonary arterial hypertension. J Thorac Imaging (2013) 0.82
Quantitative magnetic resonance imaging of pulmonary hypertension: a practical approach to the current state of the art. J Thorac Imaging (2014) 0.80
Non-invasive determination of pulmonary hypertension with dynamic contrast-enhanced computed tomography: a pilot study. Eur Radiol (2013) 0.78
Native T1 mapping and extracellular volume fraction measurement for assessment of right ventricular insertion point and septal fibrosis in chronic thromboembolic pulmonary hypertension. Eur Radiol (2016) 0.77
Myocardial fibrosis in Eisenmenger syndrome: a descriptive cohort study exploring associations of late gadolinium enhancement with clinical status and survival. J Cardiovasc Magn Reson (2014) 0.77
Review of Journal of Cardiovascular Magnetic Resonance 2012. J Cardiovasc Magn Reson (2013) 0.76
Review of Journal of Cardiovascular Magnetic Resonance 2013. J Cardiovasc Magn Reson (2014) 0.75
Non-invasive evaluation of pulmonary arterial blood flow and wall shear stress in pulmonary arterial hypertension with 3D phase contrast magnetic resonance imaging. Springerplus (2016) 0.75
Evaluation of two-dimensional strain echocardiography for quantifying right ventricular function in patients with pulmonary arterial hypertension. Exp Ther Med (2017) 0.75
Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med (1991) 13.21
Surrogate end points in clinical trials: are we being misled? Ann Intern Med (1996) 9.81
Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation (2010) 5.87
Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson (2008) 5.65
Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J (2007) 3.87
Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. J Am Coll Cardiol (2011) 3.69
Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation (1984) 3.15
Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension. Chest (2007) 2.68
Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. JACC Cardiovasc Imaging (2009) 2.56
Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol (2002) 2.50
Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study. Am J Respir Crit Care Med (2005) 2.49
A meta-analysis of trials of pulmonary hypertension: a clinical condition looking for drugs and research methodology. Am Heart J (2007) 2.42
Reference right ventricular systolic and diastolic function normalized to age, gender and body surface area from steady-state free precession cardiovascular magnetic resonance. Eur Heart J (2006) 2.35
Sex and race differences in right ventricular structure and function: the multi-ethnic study of atherosclerosis-right ventricle study. Circulation (2011) 2.30
Pulmonary vein stenosis after catheter ablation of atrial fibrillation. Circulation (1998) 2.25
Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension. Circulation (2003) 2.22
Magnetic resonance imaging analysis of right ventricular pressure-volume loops: in vivo validation and clinical application in patients with pulmonary hypertension. Circulation (2004) 2.12
Interventricular mechanical asynchrony in pulmonary arterial hypertension: left-to-right delay in peak shortening is related to right ventricular overload and left ventricular underfilling. J Am Coll Cardiol (2008) 1.97
Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support. J Cardiovasc Magn Reson (2011) 1.92
Pulmonary arterial hypertension: the key role of echocardiography. Chest (2005) 1.79
Right ventricular failure following chronic pressure overload is associated with reduction in left ventricular mass: evidence for atrophic remodeling. J Am Coll Cardiol (2011) 1.74
Flow measurement by magnetic resonance: a unique asset worth optimising. J Cardiovasc Magn Reson (2007) 1.61
Pulmonary hypertension after splenectomy? Ann Intern Med (1999) 1.55
Pulmonary arterial hypertension: noninvasive detection with phase-contrast MR imaging. Radiology (2007) 1.52
Comparison of right ventricular volume measurements between axial and short axis orientation using steady-state free precession magnetic resonance imaging. J Magn Reson Imaging (2003) 1.51
Reproducibility of MRI measurements of right ventricular size and function in patients with normal and dilated ventricles. J Magn Reson Imaging (2008) 1.51
Assessing normal pulse wave velocity in the proximal pulmonary arteries using transit time: a feasibility, repeatability, and observer reproducibility study by cardiovascular magnetic resonance. J Magn Reson Imaging (2007) 1.50
Echocardiographic features of primary pulmonary hypertension. Am J Cardiol (1974) 1.49
Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. Eur Heart J (2005) 1.43
Right ventricular ejection fraction is better reflected by transverse rather than longitudinal wall motion in pulmonary hypertension. J Cardiovasc Magn Reson (2010) 1.42
Magnetic resonance-derived 3-dimensional blood flow patterns in the main pulmonary artery as a marker of pulmonary hypertension and a measure of elevated mean pulmonary arterial pressure. Circ Cardiovasc Imaging (2008) 1.38
Right ventriculo-arterial coupling in pulmonary hypertension: a magnetic resonance study. Heart (2011) 1.33
Novel method of quantifying pulmonary vascular resistance by use of simultaneous invasive pressure monitoring and phase-contrast magnetic resonance flow. Circulation (2004) 1.32
Extent of MRI delayed enhancement of myocardial mass is related to right ventricular dysfunction in pulmonary artery hypertension. AJR Am J Roentgenol (2007) 1.28
Effects of epoprostenol on right ventricular hypertrophy and dilatation in pulmonary hypertension. Chest (2004) 1.26
Cardiac MRI and pulmonary MR angiography of sinus venosus defect and partial anomalous pulmonary venous connection in cause of right undiagnosed ventricular enlargement. AJR Am J Roentgenol (2009) 1.25
A comparison of noninvasive MRI-based methods of estimating pulmonary artery pressure in pulmonary hypertension. J Magn Reson Imaging (2005) 1.22
Impaired left ventricular filling due to right ventricular pressure overload in primary pulmonary hypertension: noninvasive monitoring using MRI. Chest (2001) 1.19
Impaired stroke volume response to exercise in pulmonary arterial hypertension. J Am Coll Cardiol (2006) 1.18
Prevalence and correlates of septal delayed contrast enhancement in patients with pulmonary hypertension. Am J Cardiol (2007) 1.15
Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. Am J Cardiol (1992) 1.15
Simvastatin as a treatment for pulmonary hypertension trial. Am J Respir Crit Care Med (2010) 1.15
Reverse right ventricular remodeling after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: utility of magnetic resonance imaging to demonstrate restoration of the right ventricle. J Thorac Cardiovasc Surg (2007) 1.15
Ventricular mass index using magnetic resonance imaging accurately estimates pulmonary artery pressure. Eur Respir J (2002) 1.14
Prevalence and characteristics of disproportionate ventricular septal thickening in patients with acquired or congenital heart diseases: echocardiographic and morphologic findings. Circulation (1977) 1.12
Reverse cardiac remodelling in patients with primary pulmonary hypertension after isolated lung transplantation. Eur J Cardiothorac Surg (2004) 1.11
Uncertainties in the diagnosis and treatment of pulmonary arterial hypertension. Circulation (2008) 1.11
Modified RV short axis series--a new method for cardiac MRI measurement of right ventricular volumes. J Cardiovasc Magn Reson (2005) 1.09
Pulmonary artery distensibility and blood flow patterns: a magnetic resonance study of normal subjects and of patients with pulmonary arterial hypertension. Am Heart J (1989) 1.06
Pulmonary artery distensibility in pulmonary arterial hypertension: an MRI pilot study. Eur Respir J (2006) 1.04
Feasibility of tissue magnetic resonance imaging: a pilot study in comparison with tissue Doppler imaging and invasive measurement. J Am Coll Cardiol (2005) 1.02
Measuring the heart in pulmonary arterial hypertension (PAH): implications for trial study size. J Magn Reson Imaging (2010) 1.00
Pulmonary arterial thrombosis in eisenmenger syndrome is associated with biventricular dysfunction and decreased pulmonary flow velocity. J Am Coll Cardiol (2007) 1.00
Right and left ventricular myocardial perfusion reserves correlate with right ventricular function and pulmonary hemodynamics in patients with pulmonary arterial hypertension. Radiology (2010) 0.99
Configuration of elastic tissue of pulmonary trunk in idiopathic pulmonary hypertension. Circulation (1960) 0.99
Interventricular septal configuration at mr imaging and pulmonary arterial pressure in pulmonary hypertension. Radiology (2005) 0.98
Visualization of flow by vector analysis of multidirectional cine MR velocity mapping. J Comput Assist Tomogr (1994) 0.96
Pulmonary arterial resistance: noninvasive measurement with indexes of pulmonary flow estimated at velocity-encoded MR imaging--preliminary experience. Radiology (1999) 0.95
Pulmonary artery sarcoma mimicking chronic thromboembolic disease: computed tomography and magnetic resonance imaging findings. Cardiovasc Intervent Radiol (1994) 0.93
Understanding late gadolinium enhancement in pulmonary hypertension. Circ Cardiovasc Imaging (2010) 0.92
Pulmonary hypertension: pulmonary flow quantification and flow profile analysis with velocity-encoded cine MR imaging. Radiology (1992) 0.91
Delayed contrast-enhanced magnetic resonance imaging in pulmonary arterial hypertension. Circulation (2005) 0.87
Right ventricular reverse remodelling after sildenafil in pulmonary arterial hypertension. Heart (2006) 0.86
Reverse right ventricular remodeling after pulmonary endarterectomy. J Thorac Cardiovasc Surg (2006) 0.86
Imaging in pulmonary hypertension. JACC Cardiovasc Imaging (2010) 0.85
Non-invasive stroke volume assessment in patients with pulmonary arterial hypertension: left-sided data mandatory. J Cardiovasc Magn Reson (2008) 0.83
Right ventricular myocardial mass quantification with magnetic resonance imaging. Am J Cardiol (1990) 0.83
Noninvasive assessment of pulmonary arterial hypertension by MR phase-mapping method. J Appl Physiol (1985) (2001) 0.83
MRI complements standard assessment of right ventricular function after lung transplantation. Ann Thorac Surg (1995) 0.81
Magnetic resonance imaging provides evidence for remodeling of the right ventricle after single-lung transplantation for pulmonary hypertension. Circulation (1996) 0.81
Right ventricular pathology in chronic pulmonary hypertension. Am J Cardiol (1996) 0.81
Functional and metabolic recovery of the right ventricle during Bosentan therapy in idiopathic pulmonary arterial hypertension. J Cardiovasc Magn Reson (2005) 0.80
Magnetic resonance imaging for quantitation of right ventricular volume in patients with pulmonary hypertension. J Thorac Imaging (1993) 0.76
Pathologic blood flow in pulmonary vascular disease as shown by gated magnetic resonance imaging. Ann Intern Med (1985) 0.76
2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J (2014) 6.32
ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J (2011) 5.11
Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA). Circulation (2013) 3.90
Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med (2008) 3.67
Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol (2011) 2.66
Updated evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol (2009) 2.57
Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study. Eur Heart J (2006) 2.49
Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study. Am J Respir Crit Care Med (2005) 2.49
Pathogenesis of high-altitude pulmonary edema: inflammation is not an etiologic factor. JAMA (2002) 2.23
Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension. Circulation (2008) 2.18
Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland. Am J Respir Crit Care Med (2012) 2.00
Applications of phase-contrast flow and velocity imaging in cardiovascular MRI. Eur Radiol (2005) 1.99
Spatio-temporal free-form registration of cardiac MR image sequences. Med Image Anal (2005) 1.81
The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe. Haematologica (2012) 1.72
Segmentation of 4D cardiac MR images using a probabilistic atlas and the EM algorithm. Med Image Anal (2004) 1.67
Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity. Blood (2011) 1.64
End points and clinical trial design in pulmonary arterial hypertension. J Am Coll Cardiol (2009) 1.63
Myocardial T2* measurements in iron-overloaded thalassemia: An in vivo study to investigate optimal methods of quantification. Magn Reson Med (2008) 1.60
Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med (2008) 1.52
emPHasis-10: development of a health-related quality of life measure in pulmonary hypertension. Eur Respir J (2013) 1.52
Assessing normal pulse wave velocity in the proximal pulmonary arteries using transit time: a feasibility, repeatability, and observer reproducibility study by cardiovascular magnetic resonance. J Magn Reson Imaging (2007) 1.50
Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights. J Am Coll Cardiol (2011) 1.48
Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry. Int J Cardiol (2012) 1.48
Patient descriptions of breathlessness in heart failure. Int J Cardiol (2005) 1.42
Black-blood T2* technique for myocardial iron measurement in thalassemia. J Magn Reson Imaging (2007) 1.41
Images in cardiovascular medicine. Occult anomalous pulmonary venous drainage: the clinical value of cardiac magnetic resonance imaging. Circulation (2002) 1.39
Myocardial T*2 measurement in iron-overloaded thalassemia: an ex vivo study to investigate optimal methods of quantification. Magn Reson Med (2008) 1.38
Effect of altitude on the heart and the lungs. Circulation (2007) 1.38
Multimodality imaging in transcatheter aortic valve implantation and post-procedural aortic regurgitation: comparison among cardiovascular magnetic resonance, cardiac computed tomography, and echocardiography. J Am Coll Cardiol (2011) 1.37
Evidence for Marfan cardiomyopathy. Eur J Heart Fail (2010) 1.35
Construction of a statistical model for cardiac motion analysis using nonrigid image registration. Inf Process Med Imaging (2003) 1.35
Role of magnetic resonance angiography in the diagnosis of major aortopulmonary collateral arteries and partial anomalous pulmonary venous drainage. Circulation (2004) 1.33
Bosentan decreases the plasma concentration of sildenafil when coprescribed in pulmonary hypertension. Br J Clin Pharmacol (2005) 1.29
Myocardial late gadolinium enhancement in specific cardiomyopathies by cardiovascular magnetic resonance: a preliminary experience. J Cardiovasc Med (Hagerstown) (2007) 1.26
Volume-selective 3D turbo spin echo imaging for vascular wall imaging and distensibility measurement. J Magn Reson Imaging (2003) 1.25
Cardiac MRI and pulmonary MR angiography of sinus venosus defect and partial anomalous pulmonary venous connection in cause of right undiagnosed ventricular enlargement. AJR Am J Roentgenol (2009) 1.25
Analysis of 3-D myocardial motion in tagged MR images using nonrigid image registration. IEEE Trans Med Imaging (2004) 1.24
Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertension. Hum Mutat (2011) 1.18
Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies. J Cardiovasc Magn Reson (2012) 1.17
Simvastatin as a treatment for pulmonary hypertension trial. Am J Respir Crit Care Med (2010) 1.15
Left ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2012) 1.15
Towards comprehensive assessment of mitral regurgitation using cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2008) 1.15
Cardiovascular magnetic resonance artefacts. J Cardiovasc Magn Reson (2013) 1.13
Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med (2008) 1.12
Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertension. Am J Respir Crit Care Med (2012) 1.11
Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension. Heart (2011) 1.09
3D volume-selective turbo spin echo for carotid artery wall imaging with navigator detection of swallowing. J Magn Reson Imaging (2005) 1.06
A qualitative study of chronic heart failure patients' understanding of their symptoms and drug therapy. Eur J Heart Fail (2002) 1.02
Prevalence of associated cardiovascular abnormalities in 500 patients with aortic coarctation referred for cardiovascular magnetic resonance imaging to a tertiary center. Pediatr Cardiol (2011) 1.01
Measuring the heart in pulmonary arterial hypertension (PAH): implications for trial study size. J Magn Reson Imaging (2010) 1.00
Pulmonary arterial thrombosis in eisenmenger syndrome is associated with biventricular dysfunction and decreased pulmonary flow velocity. J Am Coll Cardiol (2007) 1.00
Clinical utility and prognostic value of left atrial volume assessment by cardiovascular magnetic resonance in non-ischaemic dilated cardiomyopathy. Eur J Heart Fail (2013) 1.00
Images in cardiovascular medicine. Myocardial fibrosis in glycogen storage disease type III. Circulation (2003) 0.99
The association of clinical outcome with right atrial and ventricular remodelling in patients with pulmonary arterial hypertension: study with real-time three-dimensional echocardiography. Eur Heart J Cardiovasc Imaging (2012) 0.97
Therapeutic targets in pulmonary arterial hypertension. Pharmacol Ther (2008) 0.97
Nasal epithelium potential difference at high altitude (4,559 m): evidence for secretion. Am J Respir Crit Care Med (2003) 0.95
Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease. J Am Coll Cardiol (2006) 0.95
On using T2 to assess extrinsic magnetic field inhomogeneity effects on T2* measurements in myocardial siderosis in thalassemia. Magn Reson Med (2009) 0.93
Survey of specialist palliative care and heart failure: September 2004. Palliat Med (2006) 0.93
Understanding late gadolinium enhancement in pulmonary hypertension. Circ Cardiovasc Imaging (2010) 0.92
Right ventricular dysfunction is a predictor of non-response and clinical outcome following cardiac resynchronization therapy. J Cardiovasc Magn Reson (2011) 0.92
Prognostic value of cardiovascular magnetic resonance in patients with suspected arrhythmogenic right ventricular cardiomyopathy. Int J Cardiol (2013) 0.91
Safety and tolerability of bosentan in adults with Eisenmenger physiology. Int J Cardiol (2005) 0.91
Cardiovascular magnetic resonance in Marfan syndrome. J Cardiovasc Magn Reson (2013) 0.91
Images in cardiovascular medicine: Magnetic resonance angiography of a congenitally interrupted aortic arch. Circulation (2002) 0.90
Differences in ventilatory inefficiency between pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Chest (2011) 0.88
Follow up in a case of cardiac contusion using cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2007) 0.88
Validation of the isovolumetric relaxation time for the estimation of pulmonary systolic arterial blood pressure in chronic pulmonary hypertension. Eur Heart J Cardiovasc Imaging (2012) 0.86
Elimination of residual blood flow-related signal in 3D volume-selective TSE arterial wall imaging using velocity-sensitive phase reconstruction. J Magn Reson Imaging (2006) 0.86
Comparison between three-dimensional volume-selective turbo spin-echo imaging and two-dimensional ultrasound for assessing carotid artery structure and function. J Magn Reson Imaging (2005) 0.85
Long-term safety, tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease. Heart (2007) 0.85
Interstudy reproducibility of three-dimensional volume-selective fast spin echo magnetic resonance for quantifying carotid artery wall volume. J Magn Reson Imaging (2005) 0.85
Aortic papillary fibroelastoma as an unusual cause of angina: insights from multimodality imaging. Circ Cardiovasc Imaging (2011) 0.85
Supplementation of iron in pulmonary hypertension: Rationale and design of a phase II clinical trial in idiopathic pulmonary arterial hypertension. Pulm Circ (2013) 0.85
Integrated morphologic and functional assessment of the aortic root after different tissue valve root replacement procedures. J Thorac Cardiovasc Surg (2012) 0.85
The association between tricuspid regurgitation velocity and 5-year survival in a North West London population of patients with sickle cell disease in the United Kingdom. Br J Haematol (2013) 0.84
Comparison of spiral and FLASH phase velocity mapping, with and without breath-holding, for the assessment of left and right coronary artery blood flow velocity. J Magn Reson Imaging (2004) 0.84
Aberrant chloride intracellular channel 4 expression contributes to endothelial dysfunction in pulmonary arterial hypertension. Circulation (2014) 0.84
Right ventricular function in patients with pulmonary hypertension; the value of myocardial performance index measured by tissue Doppler imaging. Eur J Echocardiogr (2010) 0.83
No association between high-altitude tolerance and the ACE I/D gene polymorphism. Med Sci Sports Exerc (2002) 0.82
Cardiovascular magnetic resonance in systemic hypertension. J Cardiovasc Magn Reson (2012) 0.82
Angiosarcoma of the right atrium: a diagnostic dilemma. Int J Cardiol (2005) 0.81
Retrospective study of pulmonary hypertensive patients: is right ventricular myocardial performance index a vital prognostic factor? Hellenic J Cardiol (2007) 0.81
Morphologic and functional remodeling of the right ventricle in pulmonary hypertension by real time three dimensional echocardiography. Am J Cardiol (2011) 0.81
Right atrial flutter isthmus ablation is feasible and results in acute clinical improvement in patients with persistent atrial flutter and severe pulmonary arterial hypertension. Int J Cardiol (2011) 0.81
[2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism]. Kardiol Pol (2014) 0.81
Cardiac pseudotumor: tissue characterization by cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2003) 0.81
Exercise-induced haemoptysis: a thoroughbred cause? Thorax (2013) 0.80
Breath-hold signal-loss sequence for the qualitative assessment of flow disturbances in cardiovascular MR. J Magn Reson Imaging (2003) 0.80
3D geometric reconstruction of thoracic aortic aneurysms. Biomed Eng Online (2006) 0.80
Noninvasive detection of coronary artery wall thickening with age in healthy subjects using high resolution MRI with beat-to-beat respiratory motion correction. J Magn Reson Imaging (2011) 0.79
Myocardial scarring caused by left ventricular assist device (LVAD) insertion demonstrated by cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2003) 0.79
Clinical trials for pulmonary hypertension in the developing world: pulmonary vascular disease: the global perspective. Chest (2010) 0.78